Mitral leaflet in functional regurgitation: Passive bystander or active player?

Circulation

Volumn 120, Issue 4, 2009, Pages 275-277

  Maurer, Gerald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiomyopathy; Editorials; Growth substances; Ischemia; Mitral valve; Remodeling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; COLLAGEN; DNA; GLYCOSAMINOGLYCAN;

ADULT; AGED; BIOCHEMISTRY; CARDIOMYOPATHY; CELL ACTIVATION; CELL DIFFERENTIATION; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EDITORIAL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLUOROSCOPY; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MECHANICAL STRESS; MEMBRANE LEAFLET; MESENCHYME; MITRAL VALVE REGURGITATION; POPULATION RESEARCH; PRIORITY JOURNAL; STRESS STRAIN RELATIONSHIP; TACHYCARDIA;

ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

EID: 68249152424     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.879957     Document Type: Editorial

References (20)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
2. Burch GE, De Pasquale NP, Phillips JH. The syndrome of papillary muscle dysfunction. Am Heart J. 1968;75:399-415.
3. Mittal AK, Langston M, Cohn KE, Selzer A, Kerth WJ. Combined papillary muscle and left ventricular wall dysfunction as a cause of mitral regurgitation: an experimental study. Circulation. 1971;44:174 -180.
4. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997;96: 1826-1834.
5. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400 -1406.
6. Dal-Bianco JP, Aikawa E, Bischoff J, Guerrero JL, Handschumacher MD, Sullivan S, Johnson B, Titus JS, Iwamoto Y, Wylie-Sears J, Levine RA, Carpentier A. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation. 2009;120:334 -342.
7. Kunzelman KS, Cochran RP. Stress/strain characteristics of porcine mitral valve tissue: parallel versus perpendicular collagen orientation. J Card Surg. 1992;7:71-78.
8. De Filippo R, Atala A. Stretch and growth: the molecular and physiologic influences of tissue expansion. Plast Reconstr Surg. 2002;109: 2450-2462.
9. Grande-Allen KJ, Borowski AG, Troughton RW, Houghtaling PL, Dipaola NR, Moravec CS, Vesely I, Griffin BP. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol. 2005;45:54-61.
10. Grande-Allen KJ, Barber JE, Klatka KM, Houghtaling PL, Vesely I, Moravec CS, McCarthy PM. Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. J Thorac Cardiovasc Surg. 2005;130:783-790.
11. Timek TA, Lai DT, Dagum P, Liang D, Daughters GT, Ingels NB Jr, Miller DC. Mitral leaflet remodeling in dilated cardiomyopathy. Circulation. 2006;114(suppl):I-518-I-523.
12. Chaput M, Handschumacher MD, Tournoux F, Hua L, Guerrero JL, Vlahakes GJ, Levine RA. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation. 2008;118:845- 852.
13. Frid MG, Kale VA, Kurt R. Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res. 2002;90:1189 -1196.
14. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-deGrott AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 1997;80:444-451.
15. Paranya G, Vineberg S, Dvorin E, Kaushal S, Roth SJ, Rabkin E, Schoen FJ, Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol. 2001;159:1335-1343.
16. Gelsomino S, Lorusso R, Caciolli S, Capecchi I, Rostagno C, Chioccioli M, De Cicco G, Billè G, Stefàno P, Gensini GF. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136:507-518.
17. Lee AP, Acker M, Kubo SH, Bolling SF, Park SW, Bruce CJ, Oh JK. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. Circulation. 2009;119:2606 -2614.
18. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, for the STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009; 360:1781-1784.
19. Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Pierard LA, Bax JJ. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29:757-765.
20. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH, for the Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg. 2006; 132:568 -577.